Kalamazoo, Michigan-based Stryker received FDA clearance for the Pangea system in September 2023. On the company’s latest earnings call, CEO Kevin Lobo highlighted Pangea as a revenue growth driver in the coming quarter. Pangea provides a comprehensive, versatile portfolio of variable-angle plating for a variety of patient populations. Stryker…